Download PDF
Z Gastroenterol 2014; 52(1): 64
DOI: 10.1055/s-0034-1366796
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo

Eine randomisierte, kontrollierte Behandlungsstudie beim Reizdarmsyndrom mit einer probiotischen E.-coli-Präparation (DSM17252) im Vergleich zu Placebo
P. Enck
1   Internal Medicine VI, University Medical Hospital, Tübingen
,
K. Zimmermann
2   Symbio Herborn Group GmbH, Herborn
,
G. Menke
3   PAZ Arzneimittel-Entwicklungsgesellschaft mbH, Frankfurt/M.
,
S. Klosterhalfen
1   Internal Medicine VI, University Medical Hospital, Tübingen
› Author Affiliations
Further Information

Publication History

Publication Date:
25 June 2014 (online)

Also available at
   Permissions and Reprints

Correction to:

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to PlaceboZ Gastroenterol 2009; 47(02): 209-214
DOI: 10.1055/s-2008-1027702

Erratum „P. Enck, K. Zimmermann, G. Menke, S. Klosterhalfen. Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo. Z Gastroenterol; 2009; 47(2): 209-214, DOI: 10.1055/s-2008-1027702“

Table 2 accidentally reports data from another study. The correct table 2 reads as follows:

Table 2

Demographic data of patients in the drug and the placebo arm of the study.

Drug

Placebo

No of patients

N = 148

N = 150

Females

N = 86

N = 81

Age

48.71 (19 - 74)

48.25 (18 - 82)

Weight (kg)

69.86 (49 - 101)

70.37 (44 - 104)

BMI

24.51 (19.63 - 34.17)

24.57 (18.07 - 37.92)

No rescue medication incidences in both study arms, two cases of premature study termination because of adverse events, both in the drug arm.